alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

Term ID

CHEBI:18217

Synonyms

(Gal)2 (GlcNAc)1
alpha-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
alpha-D-Galactosyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosamine
alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcNAc
alpha-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc
alpha-gal trisaccharide
alphaGal1-3betaGal1-4GlcNAc
gal-alpha-1,3-gal-beta-1,4-GlcNAc
Galalpha1-3Galbeta1-4GlcNAc

Definition

An amino trisaccharide consisting of two D-galactose residues, linked α(1→3), and an N-acetyl-D-glucosamine residue, linked β(1→4), at the reducing end.

References

beilstein:5322979
glygen:G27798EJ
glytoucan:G27798EJ
kegg.compound:C04847
kegg.glycan:G00304
pubmed:10096519
pubmed:10355731
pubmed:11549456
pubmed:12009948
pubmed:12544864
pubmed:16442513
pubmed:17991151
pubmed:19913595
pubmed:27261450
pubmed:28472163
pubmed:9741457
reaxys:5322979

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

Phenotype where environments contain alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

Phenotype modified by environments containing alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

Phenotype affecting alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc

Human Disease Model